| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-18 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-18 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-16 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-16 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-16 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-16 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-14 |